GlassScriptPhysician profile
Michael Niccole
NPI 1801010475
$95,273.23
in general payments reported to CMS, 2019-2025
14 companies · $821 in 2025
The $821 reported for 2025 was more than what 86% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $26K · 2020: $1,018 · 2021: $1,585 · 2022: $1,824 · 2023: $47K · 2024: $17K · 2025: $821.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $63K · Food and Beverage: $1,699 · Education: $8.45.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $63,169.06 |
| Food and Beverage | $1,698.98 |
| Education | $8.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $63,890.52 | 2023-2025 | |
| Allergan, INC. | $27,264.66 | 2019-2022 | |
| Sientra, INC. | $1,887.33 | 2020-2022 | |
| Merz North America, INC. | $1,122.30 | 2020-2023 | Xeomin |
| Mentor Worldwide LLC | $369.49 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Acera Surgical, INC. | $148.38 | 2024 | Restrata Wound Matrix |
| Boston Scientific Corporation | $133.80 | 2019-2023 | Wavewriter Alpha Prime 16 |
| Pacira Pharmaceuticals Incorporated | $131.04 | 2022 | |
| Organogenesis INC. | $122.26 | 2024 | Puraply Wound Matrix |
| Galderma Laboratories, L.P. | $101.14 | 2019-2024 | |
| Apyx Medical Corporation | $38.27 | 2020 | |
| Integra Lifesciences Corporation | $33.17 | 2023 | Durasorb Monofilament Mesh |
| Tela Bio, INC. | $15.78 | 2021 | |
| Acelrx Pharmaceuticals, INC. | $15.09 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Niccole listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.